Status:
RECRUITING
Cohort SURVI : Intestinal Ischemia and Vascular Diseases
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Mesenteric Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
The first Intestinal Vascular Emergency Unit (SURVI), with the institutional support of AP-HP, opened on 4 January 2016, within the Paris-Nord Val de Seine University Hospital Group. This intensive ca...
Detailed Description
The first Intestinal Vascular Emergency Unit (SURVI), with the institutional support of AP-HP, opened on 4 January 2016, within the Paris-Nord Val de Seine University Hospital Group. This intensive ca...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- IMVI including :
- acute mesenteric ischaemia defined by acute digestive distress in relation to arterial and/or venous, occlusive and/or non-occlusive splanchnic-mesenteric vascular insufficiency, in the absence of an alternative diagnosis
- Chronic mesenteric ischaemia defined by chronic digestive distress (duration of symptom evolution \>30 days) related to occlusive or non- occlusive arterial or venous vascular insufficiency.
- MVI: gastrointestinal arterial or venous diseases without ischaemia (atheroma, embolism, thrombosis, dissection, mediolysis, aneurysm, dysplasia, sheathing, compression, torsion)
Exclusion
- Left ischaemic colitis without damage to the celiac trunk and/or superior mesenteric artery
- Dissection of the abdominal aorta without intestinal ischaemia
- Portal thrombosis without extension to the superior mesenteric vein
- Portal thrombosis without extension to the superior mesenteric vein
- Traumatic rupture of the digestive arteries
- Non-injected abdominal scanner or no abdominal scanner
- Patient opposition to participation in research
- Patient under guardianship / curators
- Vulnerable patient: pregnant or breastfeeding women, persons deprived of their liberty, minors, adults unable or unwilling to give consent
Key Trial Info
Start Date :
November 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 4 2041
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT04746534
Start Date
November 27 2020
End Date
January 4 2041
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Olivier CORCOS
Clichy, France, 92110